SeaStar Medical Holding Corporation, a commercial-stage healthcare company focused on treatments for critically ill patients, announced the pricing of a public offering. The company plans to offer 6,153,847 shares of its common stock and accompanying Series A and Series B warrants at a combined price of $0.65 per share. The offering is expected to generate approximately $4 million in gross proceeds initially, with the potential for an additional $4 million if the Series B short-term warrants are fully exercised. H.C. Wainwright & Co. is serving as the exclusive placement agent for this offering. The proceeds will be used for general corporate purposes.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。